Hoth Therapeutics, Inc.
(NASDAQ : HOTH)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson -2.60%123.280.7%$1936.14m
PFEPfizer Inc. -2.71%30.890.9%$1431.38m
MRKMerck & Co., Inc. -2.49%71.700.7%$1293.00m
ABBVAbbVie, Inc. -1.73%72.552.3%$1211.13m
BMYBristol-Myers Squibb Co. 1.07%52.811.0%$1063.11m
LLYEli Lilly & Co. -0.23%134.041.1%$895.93m
FTSVForty Seven, Inc. 0.09%94.550.0%$324.65m
NVSNovartis AG -0.51%79.330.2%$314.08m
GSKGlaxoSmithKline Plc -2.09%36.470.2%$276.86m
AZNAstraZeneca Plc 0.31%42.491.2%$268.45m
NVONovo Nordisk A/S 1.21%56.650.1%$166.60m
SNYSanofi -1.19%42.440.2%$158.34m
BHCBausch Health Cos., Inc. -6.28%14.470.0%$103.86m
RGENRepligen Corp. 1.25%92.557.1%$72.48m
RETAReata Pharmaceuticals, Inc. 0.73%149.993.4%$67.52m

Company Profile

Hoth Therapeutics, Inc. is a development stage biopharmaceutical company, which engages in the provision and development of therapeutic platform. The company focuses on the patients suffering from conditions such as atopic dermatitis, also known as eczema. It offers BioLexa Platform, a proprietary, patented, drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern in May 2017 and is headquartered in New York, NY.